Author:
Johnston L,Florek M,Armstrong R,McCune J S,Arai S,Brown J,Laport G,Lowsky R,Miklos D,Shizuru J,Sheehan K,Lavori P,Negrin R
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference51 articles.
1. Kahan BD, Camardo JS . Rapamycin: clinical results and future opportunities. Transplantation 2001; 72: 1181–1193.
2. Benito AI, Furlong T, Martin PJ, Anasetti C, Appelbaum FR, Doney K et al. Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease. Transplantation 2001; 72: 1924–1929.
3. Cutler C, Li S, Ho VT, Koreth J, Alyea E, Soiffer RJ et al. Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation. Blood 2007; 109: 3108–3114.
4. Chao NJ . Pharmacology and use of immunosuppressive agents after hematopoietic cell transplantation. In: Thomas E, Blume K, Forman S (eds) Hematopoietic Cell Transplantation, 2nd edn. Blackwell: Malden, MA, 1999 pp 176–185.
5. Cutler C, Li S, Kim HT, Laglenne P, Szeto KC, Hoffmeister L et al. Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens. Biol Blood Marrow Transplant 2005; 11: 383–388.
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献